ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,947 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaarClinuvel AG
Clinuvel AG Logo
Verified· 2 sources

Clinuvel AG

Summary

About the company

The core activity of CLINUVEL is the development, manufacture and marketing of pharmaceutical products, in particular the product SCENESSE, as well as the expansion of the business into the cosmetics sector and other services within an integrated business model.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered9
Pharmaceutical Development
Development and commercialization of treatments for genetic, metabolic, systemic and life-threatening acute conditions with unmet medical need.
Pharmaceutical Products
Pharmaceutical products based on melanocortins, including afamelanotide formulations, PRÉNUMBRA®, NEURACTHEL® and CUV9900 for skin and brain diseases.
PhotoCosmetics
Luxury skincare solutions for photoprotection, DNA repair and pigmentation, with protection against UV, UVA, UVB and HEV light.
Polychromatic Photoprotection
Broad-spectrum sunscreen with SPF 50+ against UVA, UVB and HEV light, water-resistant and with 100% mineral UV filters.
Treatment of Erythropoietic Protoporphyria (EPP)
Therapy for a rare metabolic disorder with light intolerance; part of the longitudinal care for affected patient groups.
Treatment of Vitiligo
Therapy for a skin condition with pigment loss and psychological and social burden; part of the group's focus areas.
Treatment of Variegate Porphyria (VP)
Therapy for a rare genetic disease with phototoxicity and acute attacks, for which no medical treatment exists.
Treatment of Arterial Ischemic Stroke (AIS)
Development of a therapy for arterial ischemic stroke as an acute, life-threatening indication.
Treatment of Xeroderma Pigmentosum (XP)
Development of a therapy for a rare DNA repair disorder with severe skin damage caused by light.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Comparisons

Clinuvel AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Clinuvel AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Clinuvel AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhofstrasse 9
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-114.124.927
Founded
2008 · 18 years
Last commercial register change
September 19, 2024
Employees
21 to 50

Knowledge

No knowledge articles yet

Once Clinuvel AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AP
Aalto Pharma AG
Baar
SA
Scalepharm AG
Baar
CL
Centenara Labs AG
Baar
AA
AbbVie AG
Cham
DA
Devatis AG
Cham
M(
Merck (Schweiz) AG
Zug
CH
Cilag Holding AG
Zug
SP
SGI Pharmaceuticals AG
Zug